Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collagen corneal shields--an important therapeutic modality.

K W Harrison

    Journal of Ophthalmic Nursing & Technology
    |May 1, 1989
    PubMed
    Summary

    This study introduces a collagen corneal shield, derived from porcine scleral tissue, designed for drug delivery. Different shield types dissolve within 12 to 72 hours, offering a promising ophthalmic application.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A life-cycle inventory model of municipal solid waste combustion.

    Journal of the Air & Waste Management Association (1995)·2000
    Same author

    Disposable contact lens wear systems.

    Journal of ophthalmic nursing & technology·1990
    Same author

    Gas permeable lenses--a growing trend.

    Journal of ophthalmic nursing & technology·1989
    See all related articles

    Area of Science:

    • Ophthalmology
    • Biomaterials Science
    • Drug Delivery Systems

    Background:

    • The human eye's ocular surface requires advanced therapeutic solutions.
    • Collagen-based materials offer biocompatibility for ocular applications.
    • Existing drug delivery methods for the eye have limitations.

    Purpose of the Study:

    • To evaluate a novel collagen corneal shield as a drug delivery system.
    • To characterize the dissolution profile of the collagen shield.
    • To assess the potential for repeated applications of the shield.

    Main Methods:

    • Fabrication of collagen corneal shields from porcine scleral tissue.
    • Characterization of shield dissolution times (12, 24, 72 hours).
    • Assessment of clinical applicability based on physician judgment.

    Main Results:

    • The collagen shield closely mimics human eye collagen.
    • Shields exhibit predictable dissolution rates over 12, 24, and 72 hours.
    • Physician assessment guides the suitability of repeat shield applications.

    Conclusions:

    • The collagen corneal shield is a promising biomaterial for ophthalmic drug delivery.
    • Its tunable dissolution offers flexibility in therapeutic regimens.
    • Further clinical evaluation is warranted to confirm efficacy and safety.

    Related Experiment Videos